Spain approves phase III trial for domestic COVID-19 vaccine candidate
The Spanish Agency for Medicines and Health Products has approved the final phase of clinical trials for Hipra's domestically developed COVID-19 vaccine candidate.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthSpain approves phase III trial for domestic COVID-19 vaccine candidate
Sign in or subscribeBrowse free archive reportsThe Spanish Agency for Medicines and Health Products has approved the final phase of clinical trials for Hipra's domestically developed COVID-19 vaccine candidate.